Annabelle Okada

Professor

School of Medicine, Kyorin University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Annabelle Okada is a faculty member at Kyorin University School of Medicine in Japan. Her research focuses primarily on age-related macular degeneration, including treatment efficacy and safety, machine learning applications in treatment regimens, and the management of infectious uveitis. Recent publications highlight her work on intravitreal therapies and the impact of COVID-19 on ocular conditions.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Samantha Fraser‐Bell

AUSTRALIA

View details

Arshad Khanani

University of Nevada

UNITED STATES

View details

Carlo Cagini

University of Perugia

ITALY

View details

Satoru Inoda

Jichi Medical University

JAPAN

View details

Phoebe Lin

UNITED STATES

View details

Richard P. Gale

Professor of Ophthalmology

University of York

UNITED KINGDOM

View details

Maciej Gawęcki

head of Dept

POLAND

View details

Hideki Koizumi

Professor and Chairman

University of the Ryukyus

JAPAN

View details

Bartosz Sikorski

Nicolaus Copernicus University

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Annabelle Okada

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning

TENAYA and LUCERNE: 2-Year Results from the Phase 3 nAMD Trials of Faricimab with Treat-and-Extend Dosing in Year 2

Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial

One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration

The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 2—global current practice patterns for the management of Cytomegalovirus anterior uveitis

The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1-global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis.

Incidence and Risk factors of Intraocular Inflammation after Brolucizumab Treatment in Japan: A Multicenter AMD Study

A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine

COVID Vaccine-Associated Uveitis

Collaborators (9)

Samantha Fraser‐Bell

Arshad Khanani

Carlo Cagini

Satoru Inoda

Phoebe Lin

Richard P. Gale

Maciej Gawęcki

Hideki Koizumi

Bartosz Sikorski

Make your next move.